Treffer: Data Visualization Support for Interdisciplinary Team Treatment Planning in Clinical Oncology: Scoping Review.

Title:
Data Visualization Support for Interdisciplinary Team Treatment Planning in Clinical Oncology: Scoping Review.
Authors:
Boehm D; Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Strantz C; Chair of Medical Informatics, Institute for Medical Informatics, Biometrics and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Ustjanzew A; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Manuilova I; Junior Research Group (Bio-)Medical Data Science, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Scheiter A; Institute of Pathology, University of Regensburg, Regensburg, Germany., Pauli T; Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Hechtel N; Peter L. Reichertz Institute for Medical Informatics, University of Braunschweig - Institute of Technology and Hannover Medical School, Hannover, Germany., Reimer N; Institute for Systems Biology, Lübeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany., Christoph J; Chair of Medical Informatics, Institute for Medical Informatics, Biometrics and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Junior Research Group (Bio-)Medical Data Science, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Busch H; Institute for Systems Biology, Lübeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany., Ganslandt T; Chair of Medical Informatics, Institute for Medical Informatics, Biometrics and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Unberath P; Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; SRH Fürth University of Applied Sciences, Fürth, Germany.
Source:
Journal of medical Internet research [J Med Internet Res] 2025 Dec 09; Vol. 27, pp. e69104. Date of Electronic Publication: 2025 Dec 09.
Publication Type:
Journal Article; Scoping Review
Language:
English
Journal Info:
Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-8871 (Electronic) Linking ISSN: 14388871 NLM ISO Abbreviation: J Med Internet Res Subsets: MEDLINE
Imprint Name(s):
Publication: <2011- > : Toronto : JMIR Publications
Original Publication: [Pittsburgh, PA? : s.n., 1999-
References:
JMIR Res Protoc. 2024 Mar 5;13:e53627. (PMID: 38441925)
JCO Clin Cancer Inform. 2022 Aug;6:e2200032. (PMID: 36007219)
Bioinformatics. 2017 Jul 15;33(14):2238-2240. (PMID: 28334343)
BMC Bioinformatics. 2020 Apr 15;21(1):144. (PMID: 32293247)
SN Comput Sci. 2023;4(4):358. (PMID: 37131499)
J Am Coll Surg. 2013 Sep;217(3):412-20. (PMID: 23891067)
Z Evid Fortbild Qual Gesundhwes. 2019 Jun;143:1-7. (PMID: 31296451)
Methods Inf Med. 2018 Jul;57(S 01):e50-e56. (PMID: 30016818)
JAMIA Open. 2019 Oct 07;2(4):505-515. (PMID: 32025647)
Bioinformatics. 2020 Feb 1;36(3):928-929. (PMID: 31393560)
Comput Methods Programs Biomed. 2023 Oct;240:107697. (PMID: 37441893)
BMC Med Genomics. 2020 Feb 4;13(1):17. (PMID: 32019565)
Oncologist. 2021 Aug;26(8):e1347-e1358. (PMID: 33111480)
IEEE Trans Vis Comput Graph. 2021 Mar;27(3):2220-2236. (PMID: 31514139)
PLoS One. 2013;8(2):e56228. (PMID: 23418540)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
Nat Methods. 2015 Jun;12(6):483-4. (PMID: 26020500)
JCO Precis Oncol. 2017 Jul;2017:. (PMID: 28890946)
Cancer Res. 2023 Dec 1;83(23):3861-3867. (PMID: 37668528)
Nat Cancer. 2022 Feb;3(2):251-261. (PMID: 35221333)
J Med Syst. 2016 Dec;40(12):275. (PMID: 27787779)
Semin Cancer Biol. 2022 Sep;84:271-283. (PMID: 34896635)
Int J Environ Res Public Health. 2022 Nov 14;19(22):. (PMID: 36429708)
JCO Precis Oncol. 2022 Jul;6:e2200019. (PMID: 35939770)
Brief Bioinform. 2015 Mar;16(2):280-90. (PMID: 24608524)
Cancer Discov. 2012 May;2(5):401-4. (PMID: 22588877)
Nat Genet. 2017 Jan 31;49(2):170-174. (PMID: 28138153)
Trends Cancer. 2020 Sep;6(9):738-744. (PMID: 32517959)
Bioinformatics. 2020 Jul 1;36(Suppl_1):i161-i168. (PMID: 32657368)
J Mol Diagn. 2020 Nov;22(11):1356-1366. (PMID: 32961319)
Nat Med. 2020 Jul;26(7):992-994. (PMID: 32632195)
BMC Med Inform Decis Mak. 2025 Jan 16;25(1):29. (PMID: 39819625)
BMC Health Serv Res. 2020 Jan 31;20(1):73. (PMID: 32005232)
Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
J Med Internet Res. 2022 Oct 24;24(10):e38041. (PMID: 36279164)
Stud Health Technol Inform. 2021 Nov 18;287:139-143. (PMID: 34795098)
Nucleic Acids Res. 2025 Jan 6;53(D1):D1243-D1249. (PMID: 39460617)
Bioinformatics. 2021 Jul 12;37(Suppl_1):i59-i66. (PMID: 34252935)
Stud Health Technol Inform. 2022 Nov 3;299:151-156. (PMID: 36325856)
BMC Med Inform Decis Mak. 2019 Aug 22;19(1):170. (PMID: 31438942)
Sci Signal. 2013 Apr 02;6(269):pl1. (PMID: 23550210)
Am Soc Clin Oncol Educ Book. 2014;:e461-6. (PMID: 24857140)
JCO Precis Oncol. 2018 Nov;2:1-14. (PMID: 35135153)
JCO Clin Cancer Inform. 2022 Jan;6:e2100142. (PMID: 35025671)
Stud Health Technol Inform. 2021 May 27;281:303-307. (PMID: 34042754)
Cureus. 2022 Nov 11;14(11):e31355. (PMID: 36514654)
Contributed Indexing:
Keywords: cancer conference; clinical oncology; multidisciplinary; scoping review; software; tumor; tumor board; visualization
Entry Date(s):
Date Created: 20251209 Date Completed: 20251209 Latest Revision: 20251230
Update Code:
20251230
PubMed Central ID:
PMC12728401
DOI:
10.2196/69104
PMID:
41364916
Database:
MEDLINE

Weitere Informationen

Background: Complex and expanding datasets in clinical oncology applications require flexible and interactive visualization of patient data to provide physicians and other medical professionals with maximum amount of information. In particular, interdisciplinary tumor conferences profit from customized tools to integrate, link, and visualize relevant data from all professions involved.
Objective: Our objective was to identify and present currently available data visualization tools for tumor boards and related areas. We wanted to provide an overview of not only the digital tools currently used in tumor board settings but also of the data they include, their respective visualization solutions, and their integration into hospital processes.
Methods: This scoping review was based on the scoping study framework by Arksey and O'Malley and attempted to answer the following research question: "What are the key features of data visualization solutions used in molecular and organ tumor boards, and how are these elements integrated and used within the clinical setting?" The following electronic databases were searched for articles: PubMed, Web of Science, and Scopus. Articles were deemed eligible if published in English in the last 10 years. Eligible articles were first deduplicated, followed by screening of titles and abstracts. Full-text screening was then conducted to decide on article selection. All included articles were analyzed using a data extraction template. The template included a variety of meta-information, as well as specific fields aiming to answer the research question.
Results: The review process started with 2049 articles, of which 1014 (49.49%) were included in the title and abstract screening. A total of 5.47% (112/2049) of the publications were eligible for full-text screening, leading to 2.93% (60/2049) of the publications being eligible for final inclusion. They covered 49 distinct visualization tools and applications. We discovered a variety of innovative visualization solutions, most often driven by the complexity of omics data, represented in 96% (47/49) of the tools. Tables remained the most used tool for the visualization of data types described in the articles. Approximately one-third of the identified tools (16/49, 33%) were systematically evaluated in some form. For most discovered tools (37/49, 76%), there was no documentation of implementation into the clinical routine. A significant number of applications (21/49, 43%) were available through open-source access.
Conclusions: There is a wide range of projects providing visualization solutions for tumor boards and clinical oncology applications. Among the few tools that have made their way into clinical routine settings, there are both commercial and academic solutions. While tables for a variety of data types remain the dominant visualization strategy, the complexity of omics data appears to be the driving force behind many visualization innovations in the domain of tumor boards.
International Registered Report Identifier (irrid): RR2-10.2196/53627.
(©Dominik Boehm, Cosima Strantz, Arsenij Ustjanzew, Iryna Manuilova, Alexander Scheiter, Thomas Pauli, Nicole Hechtel, Niklas Reimer, Jan Christoph, Hauke Busch, Thomas Ganslandt, Philipp Unberath. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 09.12.2025.)